Product Information

WYMZYA FE 0.4-0.035 MG CHEW TB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.5634 per EA under NDC 68180087373. Its NADAC has been published 204 times since Dec 21, 2022.

FDA first approved this application on Mar 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

WYMZYA FE 0.4-0.035 MG CHEW TB

NORETHINDRONE AND ETHINYL ESTRADIOL
$0.5634per EA

NDC

68180087373

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091332

FDA Approved

3/23/2016

TE Code

AB

On Market Since

11/30/2020

Price Statistics

The NADAC for WYMZYA FE 0.4-0.035 MG CHEW TB has been published 204 times since Dec 21, 2022, and over the history we have for it it has risen 70.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5634 per EA
All-time high$0.5634 (Nov 11, 2026)
All-time low$0.2266 (May 22, 2024)
52-week high$0.5634
52-week low$0.4892
Median price$0.4441
Average price$0.4338
Largest weekly change+57.6% (Jul 17, 2024)
Weeks tracked204
Tracking sinceDec 21, 2022

Price History

1W

0.0%

1M

+6.0%

3M

+11.7%

6M

+15.2%

1Y

+8.7%

3Y

+26.9%

5Y

N/A

All

+70.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the NORETHINDRONE AND ETHINYL ESTRADIOL market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of WYMZYA FE 0.4-0.035 MG CHEW TB?

The current National Average Drug Acquisition Cost (NADAC) for WYMZYA FE 0.4-0.035 MG CHEW TB, manufactured by Lupin Pharmaceuticals Inc., is $0.5634 per EA (NDC 68180087373), effective Nov 11, 2026.

How has the price of WYMZYA FE 0.4-0.035 MG CHEW TB changed over time?

Over the history we have for it, the NADAC for WYMZYA FE 0.4-0.035 MG CHEW TB has risen 70.5%. It has been tracked across 204 weekly CMS publications since Dec 21, 2022.

What are the highest and lowest recorded NADAC prices for WYMZYA FE 0.4-0.035 MG CHEW TB?

Since Dec 21, 2022, the NADAC for WYMZYA FE 0.4-0.035 MG CHEW TB has ranged from a low of $0.2266 (May 22, 2024) to a high of $0.5634 (Nov 11, 2026), with a median of $0.4441 per EA.

Are there cheaper alternatives to WYMZYA FE 0.4-0.035 MG CHEW TB?

No other NADAC-published product currently shares the active ingredient and strength of WYMZYA FE 0.4-0.035 MG CHEW TB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures WYMZYA FE 0.4-0.035 MG CHEW TB?

WYMZYA FE 0.4-0.035 MG CHEW TB (NDC 68180087373) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.